Abbreviated New Drug Application (ANDA)

An ANDA (ANDA) is an abbreviated version of an New Drug Application (NDA). It is allowed for duplicates of drug products that were first approved before October 10, 1962 and for certain other drugs which are described in the CFR. Its main use is to obtain FDA approval for generic drugs.


Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.